Interestingly, there was a significant link between the proliferation of the primary cancer cells (% Ki-67) and the killing capacity of the activated T cells towards adapted MCF-7 cancer cells, suggesting that low proliferative breast cancers might be less sensitive to T cell killing (Fig. 5b, Supplementary Table 10). The gene discussed is MKI67; the disease is breast carcinoma.